BioCryst’s drug development technology, pipeline and history


Guest: Dr. Bill Sheridan, Chief Medical Officer, BioCryst Pharmaceuticals, Durham

Topics: BioCryst’s drug development technology, pipeline and history; emergency use of IV peramivir, BioCryst’s anti-influenza drug, in 2009 H1N1 flu epidemic

sheridanphoto.jpg
Dr. Bill Sheridan, Sr. VP and Chief Medical Officer, BioCryst Pharmaceuticals, Inc., Durham

BioCryst Pharmaceuticals, Inc.

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s